# A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye

> **NCT01558999** · PHASE2 · COMPLETED · sponsor: **Seikagaku Corporation** · enrollment: 150 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** High concentration SI-614
- **DRUG:** Low concentration SI-614
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01558999
- **Lead sponsor:** Seikagaku Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-07
- **Final completion:** —
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558999, "A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01558999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*